A comprehensive framework for health professionals assessing COPD patients- evidence-based approach to management, how to decide whether inhaled corticosteroids are appropriate and how, when and for how long they should be used.
Treat exacerbations early, use antibiotics if you suspect an infection, add prednisolone to shorten the duration of exacerbation- for those recently hospitalised for COPD exacerbation, ensure you send to a cardiologist for full cardiac workup to exclude heart failure, ischaemia and arrhythmia.
In this Product Explainer, Prof Christine Jenkins, Head of the Respiratory Group at The George Institute for Global Health; and Senior Staff Specialist in Thoracic Medicine at Concord Hospital explains the role of a triple-therapy combination, pressurised meter dose inhaler for adults with moderate to very severe COPD. (4 mins).
In this Product Explainer, Prof Hubertus Jersmann, Respiratory and Sleep Physician at the Royal Adelaide Hospital explains how to prepare and use a reusable soft mist inhaler (5 mins).
In this Product Explainer, Dr Christopher Worsnop, Respiratory and Sleep Physician at the Austin Hospital, Melbourne explains how to use a triple-therapy combination preventer inhaler, as well as when and to whom to prescribe to in the maintenance treatment of asthma (5 mins).
In this Healthed lecture, Prof Christine Jenkins will cover the most current, evidence-based recommendations across all areas of COPD from diagnosis to management and treatment which can help change the trajectory for those patients with severe COPD.
In this Healthed webcast, A/Prof Christopher Worsnop outlines a very practical approach for doctors faced with the challenge of treating asthma patients who were prescribed textbook treatments.
In this Healthed lecture, Dr Greg Katsoulotos presents a practical guide to new therapies that are now available and where they fit in the treatment algorithm for severe asthma.
Psychologist; Director, UNSW Ageing Futures Institute; ARC Laureate Fellow; Senior Principal Research Scientist, NeuRA
Scientia Prof Kaarin Anstey translates the WHO's updated 2026 dementia risk-reduction guidelines changes into concrete actions for opportunistic risk assessment and targeted advice in everyday general practice.
Podcasts
Clinical Articles
Videos
